Arkolith/Insider Trading/LBRX/Form 4

Deep Track Capital, LP

10% OwnerLB PHARMACEUTICALS INC (LBRX) · full profile →Form 4 · filed Sep 16, 2025
Net Buying
Open-Market Buys
$40.0M
Open-Market Sells
$0
Net Open-Market Flow
$40.0M
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 12, 2025Conversion(C)686K——686K
Sep 12, 2025Buy(P)2.0M$15.00$30.0M2.7M
Sep 12, 2025Buy(P)667K$15.00$10.0M667K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 12, 2025Conversion(C)16.7M——0

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002015536-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML